Agilon Health, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K covers the results of the Annual Meeting of Stockholders held by Agilon Health, Inc. on May 28, 2025. The filing details the voting outcomes for director elections, auditor ratification, and executive compensation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance voting results.
Material Changes and Voting Results
The following proposals were submitted to a vote of security holders:
- Proposal 1: Election of Directors
- Silvana Battaglia: Elected with 367,732,187 votes for, 2,575,657 against, and 73,996 abstentions.
- Sharad Mansukani, M.D.: Elected with 316,017,915 votes for, 54,325,054 against, and 38,871 abstentions.
- Both directors serve as Class I directors until the 2028 annual meeting.
- Proposal 2: Ratification of Independent Auditor
- Stockholders ratified Ernst & Young LLP for the fiscal year ending December 31, 2025.
- Votes: 385,547,549 for, 4,346,548 against, 65,644 abstained.
- Proposal 3: Non-Binding Vote on Executive Compensation
- Stockholders approved the advisory vote on executive compensation.
- Votes: 286,771,841 for, 83,515,983 against, 94,016 abstained.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Sharad Mansukani, M.D. received a significant number of "Against" votes (54.3 million) compared to Silvana Battaglia (2.6 million), despite both being elected.
- The "Say on Pay" proposal (Proposal 3) received approximately 22.6% of votes cast against it (83.5 million against vs. 286.8 million for).
- Ernst & Young LLP was reappointed as the independent auditor for the 2025 fiscal year.
- Broker non-votes totaled 19,577,901 for the director election and executive compensation proposals.